Brown Brothers Harriman & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.66K	Hold
2025 Q2	$1.96K	Buy
2023 Q2	–	Sell
2023 Q1	$108K	Buy